网络安全检测|网络安全服务|网络安全扫描-香港墨客投资移动版

At the same time, incidents of various types of aging diseases have risen dramatically. According to the China Tumor Monitoring Annual Report of 2017, about ten thousand people are diagnosed with cancer every day, i.e, about seven people are diagnosed per minute. There are more than 200 million patients with cardiovascular diseases in China currently. Four out of every ten deaths are due to cardiovascular disease, which is higher than the death rate from tumor. Cardiovascular diseases and malignant tumors account for more than 70% of all disease deaths.

Gu Kaiqiang believes that the telomere and telomerase detection could supplement disease diagnoses at early stage. This market is unimaginably huge because it is closely related to the everyone’s health.

Dr. Ma Wenbin said bluntly that “the cost of telomere detection in the US and Europe is relatively high while the information is relatively little. However, Chinese scientists could have more precise scientific interpretations as they can collected a large number of samples at the earlier phase, especially the data of how different lifestyle affects telomere length.” He mentioned that in the telomere detection field, China not only has advantages, but has already ascended to the world’s top level. This biological detection is not harmful to human body. It could estimate the basic health condition, screen for the risk of early cancer and cardiovascular and cerebrovascular disease, and enable individuals to know their aging status and disease risks from the perspective of cellular level, molecular level and gene level. The test results could provide personalized health management suggestions and ultimately enable individuals delay the aging process in a healthy way.

Gu Kaiqiang says he is fortunate to be able to assemble this team of excellent scientists in this exciting era. He hopes that the sophisticated medical detection and follow-up health management could improve everyone’s healthy for a more exciting life, while providing the platform where the scientists can make more impactful contributions to humankind.

Invited to the forum, chairman of NASDAQ-listed Dragon Victory International Holdings Limited, Sun Jianjun and Jiangsu Kaiqiang Medical Diagnostics Co., Ltd. signed a strategic collaboration agreement. Sun Jianjun says that his group is optimistic about the top talents, the science and technology at Kaiqiang Medical Diagonostics and the immense healthcare industry. They will use the advantages of their own capitals to drive the advancement of this industry and take Kaiqiang Diagnostics as an example to elevate it into the international marketplace.

来源：     | 作者：    | 责编：李斌    审核：张渊

新闻投稿：184042016@qq.com    新闻热线：13157110107